Ratings Sociedad Química y Minera de Chile S.A. Santiago S.E.

Equities

SQM-B

CLP8716X1082

End-of-day quote Santiago S.E. Other stock markets 03:30:00 01/07/2024 am IST			5-day change	1st Jan Change
38,320 ^CLP	+0.77%		-1.11%	-27.22%

31/05	Top Midday Stories: SQM, Codelco to Mine Lithium; Moderna Gets Approval for RSV Vaccine; Tesla Recalls Over 100,000 Cars; Icahn Amasses Stake in Caesars	MT
31/05	Codelco Signs Deal With SQM, Enters Lithium Market	MT

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
The group's activity appears highly profitable thanks to its outperforming net margins.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company is one of the best yield companies with high dividend expectations.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Analyst opinion has improved significantly over the past four months.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company's earnings growth outlook lacks momentum and is a weakness.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Revenue estimates are regularly revised downwards for the current and coming years.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-27.22%	1.16TCr	-
ECOLAB INC.	+18.73%	6.8TCr	A-
SIKA AG	-6.80%	4.59TCr	A-
GIVAUDAN SA	+23.48%	4.37TCr	B+
FUJIFILM HOLDINGS CORPORATION	+32.88%	2.82TCr	A-
EMS-CHEMIE HOLDING AG	+8.59%	1.92TCr	C+
CELANESE CORPORATION	-15.25%	1.47TCr	B+
POSCO FUTURE M CO., LTD.	-25.07%	1.45TCr	A-
ALBEMARLE CORPORATION	-32.58%	1.12TCr	C+
NITTO DENKO CORPORATION	+20.52%	1.11TCr	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes